Research Education Core
研究教育核心
基本信息
- 批准号:10762085
- 负责人:
- 金额:$ 19.72万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-09-24 至 2028-08-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAmerican Society of Clinical OncologyBasic Cancer ResearchBiometryBone Marrow TransplantationCancer CenterCareer ChoiceCareer MobilityCaringClinicalClinical OncologyClinical TrialsCommunitiesDevelopmentDiagnosisDoctor of PhilosophyEducationEducational workshopEffectivenessEvaluationExposure toFacultyFeedbackFellowship ProgramFloridaGoalsGrantHealth Disparities ResearchHealth SciencesHematologyHispanicImmersionIndustryInterest GroupIslandLatinoLatino PopulationMalignant NeoplasmsMedicalMedical StudentsMentorsMentorshipNeeds AssessmentOncologistOncologyOperative Surgical ProceduresOutcomeParticipantPopulationPositioning AttributePostdoctoral FellowPreventionPuerto RicanPuerto RicoResearchResearch PersonnelResidenciesRotationScholarshipScience, Technology, Engineering and MathematicsScientistSeriesSiteStudentsSurgical OncologyTrainingUniversitiesUrologyVisionWritinganticancer researchcancer clinical trialcancer health disparitycancer therapycareercareer developmentclinical practiceclinical trainingcultural competencedesigndoctoral studenteducation researchexperiencefaculty mentorgraduate schoolhealth disparityimprovedinterestinvestigator trainingminority healthpatient engagementpeer coachingpost-doctoral trainingpre-doctoralprogramsrecruitsenior facultysuccesssummer researchtumorundergraduate student
项目摘要
ABSTRACT | RESEARCH EDUCATION CORE
The Research Education Core (REC) of the Ponce Health Sciences University and Moffitt Cancer Center
Partnership has built an educational program that supports participants across the career continuum preparing
them for basic or clinical oncology-related careers. The long-term goal of the REC is to increase the recruitment,
advancement, and quality of cancer research scientists and oncologists from the Puerto Rican and
Hispanic/Latino (H/L) population while advancing health disparities research focused on this population. Through
ongoing interactions with all components of the Partnership, the REC’s educational framework (2007-2022) has
resulted in: 125 participants obtaining faculty, medical, or industry/federal/academic positions with 30 in
hematology-oncology clinical practice; completion of 137 research rotations by PhD, MD or PsyD students;
guidance of 22 Early-Stage Investigators (ESIs); and the creation of new courses, clerkships, and robust cancer
and health disparities seminar series. Leveraging our prior successes the REC strategy is designed to jointly
engage participants across career levels and institutes to create a lasting peer mentoring network which will be
accomplished under the following aims: Aim 1 engages H/L undergraduate students at both PHSU and MCC,
eight total per year, in a new two-year-plus program with year-round mentoring and research experiences
combined with intensive summer research immersion to promote conceptual change in preconceived ideas of
limited opportunities and ‘fit’ for STEM and cancer research. Aim 2 establishes two-year diversity post-doctoral
scholarships at MCC for H/L fellows to support career success with a focus on cancer health disparities and
minority health; and also establishes career development scholarships for late-stage PHSU PhD students to
support career enhancement activities and successful transition to post-doctoral training. Two rolling scholarship
slots are available at each site. The scholarships are interwoven with training in cultural competency,
professionalism, scientific writing, and health disparities to successfully promote a path toward independence.
Aim 3 addresses the need to increase the number of H/L medical residents and medical students entering an
oncology career track. REC will facilitate the creation of the first urology residency program in PR, enable surgical
oncology training at MCC for two PR surgical residents per year, and immerse eight medical students per year
in a summer cancer research experience alongside PhD students. Aim 4 enhances the career development of
ESIs by providing individualized support for each ESI through collaborative interactions, health disparities
training, grant/scientific writing workshops, career development activities, identifying networking opportunities,
and tracking, and evaluating ongoing mentorship and sponsorship. In sum, REC trainees will gain cancer
research and health disparities experience through exposure to Partnership projects and Cores. The REC
outcomes will support the overall Partnership objectives by building and strengthening trainee career pathways
at critical career transition points, resulting in a more diverse pool of oncologists and research scientists.
摘要|研究教育核心
庞塞健康科学大学和莫菲特癌症中心的研究教育核心(REC)
伙伴关系建立了一个教育计划,支持参与者在整个职业生涯的准备
他们的基本或临床肿瘤学相关的职业。REC的长期目标是增加招聘,
来自波多黎各的癌症研究科学家和肿瘤学家的进步和质量,
西班牙裔/拉丁裔(H/L)人口,而推进健康差距的研究集中在这一人群。通过
通过与伙伴关系所有组成部分的持续互动,区域经济委员会的教育框架(2007-2022年)
结果:125名参与者获得了教师,医疗或工业/联邦/学术职位,其中30人在
血液肿瘤学临床实践;博士,医学博士或PsyD学生完成137个研究轮换;
22个早期研究者(ESI)的指导;以及创建新的课程,见习和强大的癌症
和健康差距研讨会系列。利用我们先前的成功,REC战略旨在共同
让不同职业层次和机构的参与者参与进来,建立一个持久的同行指导网络,
根据以下目标完成:目标1从事H/L本科生在PHSU和MCC,
每年8个,在一个新的两年多的计划,全年的指导和研究经验
结合密集的夏季研究浸泡,以促进在先入为主的观念,
有限的机会和'适合'干和癌症研究。目标2建立两年的多样性博士后
MCC为H/L研究员提供奖学金,以支持职业成功,重点关注癌症健康差异,
少数民族健康;并为后期PHSU博士生建立职业发展奖学金,
支持职业发展活动和顺利过渡到博士后培训。两个滚动奖学金
每个站点都有插槽。奖学金与文化能力培训交织在一起,
专业精神,科学写作和健康差异,以成功地促进独立的道路。
目标3解决了需要增加H/L医学住院医师和医学生进入
肿瘤学的职业轨迹REC将促进在PR创建第一个泌尿外科住院医师计划,
每年在MCC为两名PR外科住院医师提供肿瘤学培训,每年有八名医学生参加
与博士生一起进行夏季癌症研究。目标4促进以下人员的职业发展
通过协作互动为每个ESI提供个性化支持,
培训、赠款/科学写作讲习班、职业发展活动、确定联网机会,
跟踪和评估正在进行的指导和赞助。总之,REC学员将获得癌症
通过接触伙伴关系项目和核心项目,体验研究和健康方面的差距。所述REC
成果将通过建立和加强受训人员的职业发展途径,支持伙伴关系的总体目标
在关键的职业过渡点,导致肿瘤学家和研究科学家的更多样化的池。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KENNETH Lynn WRIGHT其他文献
KENNETH Lynn WRIGHT的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KENNETH Lynn WRIGHT', 18)}}的其他基金
Natural Killer Cell Regulation by PRDM1 and IRF4/8
PRDM1 和 IRF4/8 的自然杀伤细胞调节
- 批准号:
8505619 - 财政年份:2013
- 资助金额:
$ 19.72万 - 项目类别:
Natural Killer Cell Regulation by PRDM1 and IRF4/8
PRDM1 和 IRF4/8 的自然杀伤细胞调节
- 批准号:
8685196 - 财政年份:2013
- 资助金额:
$ 19.72万 - 项目类别:
PRDI-BF1 and histone methyltransferase in lymphoma
淋巴瘤中的 PRDI-BF1 和组蛋白甲基转移酶
- 批准号:
7101052 - 财政年份:2005
- 资助金额:
$ 19.72万 - 项目类别:
PRDI-BF1 and histone methyltransferase in lymphoma
淋巴瘤中的 PRDI-BF1 和组蛋白甲基转移酶
- 批准号:
7226276 - 财政年份:2005
- 资助金额:
$ 19.72万 - 项目类别:
PRDI-BF1 and histone methyltransferase in lymphoma
淋巴瘤中的 PRDI-BF1 和组蛋白甲基转移酶
- 批准号:
6906698 - 财政年份:2005
- 资助金额:
$ 19.72万 - 项目类别:
相似海外基金
EVALUATION OF IOWA CANCER REGISTRY DATA LINKAGE WITH AMERICAN SOCIETY OF CLINICAL ONCOLOGY (ASCO) CANCERLINQ. POP 9/10/19 - 9/9/20.
评估爱荷华州癌症登记处与美国临床肿瘤学会 (ASCO) CANCERLINQ 的数据链接。
- 批准号:
10026959 - 财政年份:2019
- 资助金额:
$ 19.72万 - 项目类别:














{{item.name}}会员




